Target intelligence / Profile preview

Stomatin (STOM)

Target
STOM
Molecular classification
Integral membrane protein, SPFH domain (Stomatin/Prohibitin/Flotillin/HflK/C) family, Lipid raft-associated protein
01

Overview

Stomatin is a highly conserved, 31 kDa monotopic integral membrane protein, primarily found in red blood cells but expressed widely across tissues[1][2][6]. It is a member of the SPFH (Stomatin/Prohibitin/Flotillin/HflK/C) domain family and associates with cholesterol-rich domains (lipid rafts) in the plasma membrane, where it acts as a scaffolding protein regulating the activity of numerous ion channels and transporters, including anion exchanger 1 (AE1) and glucose transporter (GLUT1)[5][7]. Stomatin plays a structural role in organizing membrane architecture, modulating ion transport, and influencing processes such as cell division and membrane fusion[3][5]. Loss of stomatin or its mislocalization is linked to hereditary stomatocytosis, a form of hemolytic anemia characterized by sodium and potassium leakage from red blood cells[1][2][6]. There is currently no direct therapeutic targeting of stomatin, but its deficiency or dysfunction serves as a molecular marker in selected blood and bone disorders.

Other names
StomatinBND7EPB72Erythrocyte band 7 integral membrane proteinErythrocyte membrane protein band 7.2Protein 7.2bEPB7erythrocyte surface protein band 7.2
02

Biological functions

Regulation of ion transmembrane transportRegulation of acid-sensing ion channel activityScaffolding in cholesterol-rich membrane microdomainsModulation of transport proteins, including anion exchangers and glucose transportersInvolvement in cell division (cytokinesis)Modulation of cell-cell fusion (e.g., osteoclastogenesis)
03

Disease associations

Hemolytic anemia (hereditary stomatocytosis)Bone diseases (e.g., increased bone resorption/osteoporosis via increased cell fusion)Possibly implicated in hypertension
04

Safety considerations

Loss of protein associated with hereditary stomatocytosis and altered red blood cell ion homeostasis[1][2][6]
05

Biomarkers

Loss of stomatin expression/localization as a biomarker for hereditary stomatocytosis[1][2][6]

Beyond the preview

Go deeper on Stomatin (STOM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stomatin (STOM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call